Article PDF
References
Zaugg M, Tagliente T, Silverstein JH, Lucchinetti E. Atenolol may not modify anesthetic depth indicators in elderly patients — a second look at the data. Can J Anesth 2003; 50: 638–42.
Ginsburg RS, Lippmann M. Is intravenous esmolol an acceptable substitute for an inadequate anesthetic? Anesth Analg 1992; 74: 776–7.
Johansen JW, Flaishon R, Sebel PS. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology 1997; 86: 364–71.
Johansen JW, Schneider G, Windsor AM, Sebel PS. Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth Analg 1998; 87: 671–6.
Johansen JW. Esmolol promotes electroencephalographic burst suppression during propofol/alfentanil anesthesia. Anesth Analg 2001; 93: 1526–31.
Menigaux C, Guignard B, Adam F, Sessler DI, Joly V, Chauvin M. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. Br J Anaesth 2002; 89: 857–62.
Smith I, Van Hemelrijck J, White PF. Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia. Anesth Analg 1991; 73: 540–6.
Coloma M, Chiu JW, White PF, Armbruster SC. The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery. Anesth Analg 2001; 92: 352–7.
Betts TA, Alford C. Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol 1985; 28(Suppl): 65–8.
Kayed K, Godtlibsen OB. Effects of the beta-adrenoceptor antagonists acebutolol and metoprolol on sleep pattern in normal subjects. Eur J Clin Pharmacol 1977; 12: 323–6.
Thompson DF, Pierce DR. Drug-induced nightmares. Ann Pharmacother 1999; 33: 93–8.
Yamada Y, Shibuya F, Hamada J, Sawada Y, Iga T. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy. J Pharmacokinet Biopharm 1995; 23: 131–45.
Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 1987; 221: 155–8.
Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L. Melatonin secretion related to sideeffects of beta-blockers from the central nervous system. Acta Med Scand 1988; 223: 525–30.
Przybyslawski J, Roullet P, Sara SJ. Attenuation of emotional and nonemotional memories after their reactivation: role of beta adrenergic receptors. J Neurosci 1999; 19: 6623–8.
Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature 1994; 20: 702–4.
Cahill L, van Stegeren A. Sex-related impairment of memory for emotional events with beta-adrenergic blockade. Neurobiol Learn Mem 2003; 79: 81–8.
Matousek M, Hjalmarson A, Koch J, Petersen I. The use of the EEG for assessment of vigilance changes caused by beta-blockers. Neuropsychobiology 1984; 12: 55–9.
de Oliveira GG, Borges MA. Propranolol action in chronically unstable generalized epilepsy. Am J Ther 1994; 1: 38–41.
Fischer W. Anticonvulsant profile and mechanism of action of propranolol and its two enantiomers. Seizure 2002; 11: 285–302.
Luchowska E, Luchowski P, Wielosz M, Kleinrok Z, Czuczwar SJ, Urbanska EM. Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock. Pharmacol Biochem Behav 2002; 71: 223–31.
van den Broek WW, Leentjens AF, Mulder PG, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a doubleblind, placebo-controlled study. Br J Anaesth 1999; 83: 271–4.
McCall WV, Zvara D, Brooker R, Arias L. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT. Convuls Ther 1997; 13: 175–80.
Howie MB, Black HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg 1990; 71: 384–8.
Kovac AL, Goto H, Pardo MP, Arakawa K. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy. Can J Anaesth 1991; 38: 204–9.
Jones RS, Olpe HR. Pharmacological characterization of the receptor mediating the adrenergic inhibition of responses to substance P in the cingulate cortex. Brain Res 1986; 367: 151–61.
Stoop R, Epiney S, Meier E, Pralong E. Modulation of epileptiform discharges in the rat limbic system in vitro by noradrenergic agents. Neurosci Lett 2000; 287: 5–8.
Davidson EM, Doursout MF, Szmuk P, Chelly JE. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats. Can J Anesth 2001; 48: 59–64.
Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain 2000; 84: 339–46.
Gorczynski RJ, Shaffer JE, Lee RJ. Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action. J Cardiovasc Pharmacol 1983; 5: 668–77.
Morales-Aguilera A, Vaughan Williams EM. The effects on cardiac muscle of β-receptor antagonists in relation to their activity as local anaesthetics. Br J Pharmcol 1965; 24: 332–8.
Vaughan Williams EM. Mode of action of beta receptor antagonists on cardiac muscle. Am J Cardiol 1966; 18: 399–405.
Berkenstadt H, Loebstein R, Faibishenko I, Halkin H, Keidan I, Perel A. Effect of a single dose of esmolol on the bispectral index scale (BIS) during propofol/fentanyl anaesthesia. Br J Anaesth 2002; 89: 509–11.
Orme R, Leslie K, Umranikar A, Ugoni A. Esmolol and anesthetic requirement for loss of responsiveness during propofol anesthesia. Anesth Analg 2002; 94: 112–6.
Larson MD, Sessler DI, Washington DE, Merrifield BR, Hynson JA, McGuire J. Pupillary response to noxious stimulation during isoflurane and propofol anesthesia. Anesth Analg 1993; 76: 1072–8.
Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit 1994; 10: 392–404.
Barr G, Anderson RE, Owall A, Jakobsson JG. Effects on the bispectral index during medium-high dose fentanyl induction with or without propofol supplement. Acta Anaesthesiol Scand 2000; 44: 807–11.
Barr G, Anderson RE, Owall A, Jakobsson JG. Being awake intermittently during propofol-induced hypnosis: a study of BIS, explicit and implicit memory. Acta Anaesthesiol Scand 2001; 45: 834–8.
Wu CC, Mok MS, Lin CS, Han SR. EEG-bispectral index changes with ketamine versus thiamylal induction of anesthesia. Acta Anaesthesiol Sin 2001; 39: 11–5.
Sakai T, Singh H, Mi WD, Kudo T, Matsuki A. The effect of ketamine on clinical endpoints of hypnosis and EEG variables during propofol infusion. Acta Anaesthesiol Scand 1999; 43: 212–6.
Coste C, Guignard B, Menigaux C, Chauvin M. Nitrous oxide prevents movement during orotracheal intubation without affecting BIS value. Anesth Analg 2000; 91: 130–5.
Russell IF, Wang M. Absence of memory for intraoperative information during surgery with total intravenous anaesthesia. Br J Anaesth 2001; 86: 196–202.
Sandin RH, Enlund G, Samuelsson P, Lennmarken C. Awareness during anaesthesia: a prospective case study. Lancet 2000; 355: 707–11.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, H., Fayad, A. Are β-blockers anesthestics?. Can J Anaesth 50, 627–630 (2003). https://doi.org/10.1007/BF03018700
Issue Date:
DOI: https://doi.org/10.1007/BF03018700